HIGHLIGHTS
- who: Yen-Chun Chen from the Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Township, Chiayi, Chiayi County, Taiwan have published the paper: A nationwide cohort study suggests clarithromycin-based therapy for, in the Journal: (JOURNAL) of December/31,/2015
- what: The authors selected stable CHD patients because the authors aimed to investigate the risk of clarithromycin in such a population similar to the CLARICOR trial . By analyzing the NHI claims data with a highly representative sample, this study has five strengths.
- how: For avoiding survival bias the authors selected eligible . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.